Ascent Health and Wellness Solutions Revenue and Competitors

Claim your profile

Mumbai, India

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Ascent Health and Wellness Solutions's estimated annual revenue is currently $12.9M per year.(i)
  • Ascent Health and Wellness Solutions's estimated revenue per employee is $100,500

Employee Data

  • Ascent Health and Wellness Solutions has 128 Employees.(i)
  • Ascent Health and Wellness Solutions grew their employee count by 28% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$161M39411%N/AN/A
Add Company

keywords:N/A

N/A

Total Funding

128

Number of Employees

$12.9M

Revenue (est)

28%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ascent Health and Wellness Solutions News

2022-04-20 - 2021-22 Rewind: Injuries derailed Jackson’s ascent as Pistons bench spark

2021-22 Rewind: Injuries derailed Jackson's ascent as Pistons bench spark ... was extended by a stint in NBA health and safety protocols.

2022-04-20 - Apple hired the same anti-union law firm as Starbucks: report

Despite its steady ascent to becoming one of the world's most ... including health care, tuition reimbursement, new parental leave,...

2022-04-17 - Healthcare Outsourcing Market Size, Outlook And Forecast ...

Outsource Strategies International, Mediscript, Medryte Healthcare Solutions, Piranah Healthcare, Exel BPO Solutions, Ascent Health...

2019-08-26 - Everstone picks up minority stake in stent company Translumina

Everstone's expertise in healthcare will help unlock the company's full ... domestic pharma distribution platform Ascent Health, and Southeast ...

2019-08-04 - Temasek lining up $100 million for Ascent Health and Wellness

NEW DELHI: Temasek is finalising an estimated $100 million equity financing round in Ascent Health and Wellness, as global investors ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M1285%N/A
#2
$22.4M12828%N/A
#3
$17.1M128-3%N/A
#4
$11.7M128-26%N/A
#5
$9.6M128-4%N/A